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Abstract 
Background: It has been demonstrated that concentrations of certain amino acids 
in the egg, in late-term embryos, are not sufficient to fully support embryonic 
development. One of the methods to assure an adequate nutrient content in the 
egg is in ovo administration of nutrients, which increases hatching weight and 
the size of the breast muscle. The small size of silver nanoparticles allows for 
penetration inside tissues and even enables them to cross cell membranes. Indeed 
it has been shown that nanoparticles of silver applied in ovo can up-regulate the 
expression of fibroblast growth factor and vascular endothelial growth factor. 
We have therefore tested if silver nanoparticles can affect muscle development 
of chicken embryos and, furthermore, if they can be used in in ovo nutrition as 
carriers of nutrients e.g. glutamine into muscle cells.   
Methods: 160 broiler eggs were randomly divided into the control group 
(Control) without injection and injected groups with hydrocolloids of 
nanoparticles of silver (Nano-Ag), glutamine (Glu) and the complex of 
nanoparticles of silver and glutamine (Nano-Ag/Glu). The embryos were 
evaluated on day 20 of incubation. Samples of the breast muscles were collected 
for gene expression analysis or fixed for electron microscopy preparation.
Results: Results indicate a significant role of silver nanoparticles and the 
complex Nano-Ag/Glu in muscle development. 
Conclusion: Nanoparticles of Ag, glutamine and the complexes of Ag and 
glutamine were without negative effects on embryo development. Nanoparticles 
of Ag and the complex of Ag with glutamine increased the number of nuclei per 
cell number and also fiber area. Furthermore, the complex of Ag with glutamine 
increased muscle mass.
Keywords: silver nanoparticles, muscle, glutamine, nutrition, gene expression, 
chicken embryo.
Introduction
Muscle growth and development consist of two periods, hyperplasia and 
hypertrophy1; while hyperplasia (an increase in the number of muscle cells) mostly 
occurs during embryogenesis the hypertrophy (an increase in the volume of muscle 
cells) takes place during the post hatching growth2, 3. During the embryonic period 
of muscle development there are three distinct stages: the formation of myoblasts, 
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the fusion of myoblasts to form myotubes and the conversion of myotubes to form 
myofibers4. This pattern of development is regulated and controlled by a variety of 
genes and depends on the availability of nutrients stored within eggs. Consequently, 
an adequate supply of nutrients is critical for embryonic development.  One of the 
methods to assure an adequate nutrient content in the egg is in ovo administration 
of nutrients, which increases hatching weight and the size of breast muscle5, 6, 
7, 8. However, this method has drawbacks, including interference with embryo 
homeostasis and the risk of microbial hazards not to mention the proper transport and 
distribution of supplemented nutrients.
Silver nanoparticles have different physical and chemical characteristics 
compared to their larger equivalents because of a very high surface to volume 
ratio, physical activity and chemical stability9, 10.  The small size of nanoparticles 
allows for penetration inside tissues and even enables them to cross cell 
membranes11, 12, 13. In vivo studies demonstrated that silver nanoparticles used at a 
low level were non-toxic and did not affect immune responses14, 15. 
Recently, it has been shown that nanoparticles of silver applied in ovo can 
up-regulate the expression of fibroblast growth factor 2 (FGF2) and vascular 
endothelial growth factor (VEGF)11. FGF2 stimulates satellite cell proliferation 
and differentiation, as well as 
angiogenesis1, while VEGF 
stimulates vasculogenesis 
and angiogenesis of muscle 
tissue16. Therefore, it is 
important to investigate 
whether silver nanoparticles 
can affect the expression 
of the other genes involved 
in chicken embryo muscle 
development. The key 
genes responsible for 
sustained muscle growth 
and development during 
embryogenesis are myogenic 
differentiation factor 
(MyoD1), pair box transcription factor 7 (Pax 7), proliferating cell nuclear 
antigen (PCNA) and ATPase (ATP1A1). MyoD1 belongs to the family of 4 basic 
helix-loop-helix transcription factors, which activate the myogenic programme 
and control muscle-specific gene expression17, whilst PCNA plays a key role in 
embryonic DNA synthesis during the cell cycle within the nuclei. Skeletal muscle 
growth is also related to the satellite cell population, which is controlled by Pax 7. 
ATP1A1 is involved in maintaining electrochemical gradients of Na+ and K+ ions 
across the plasma membrane, which is responsible for osmoregulation, electrical 
excitability, and consequently for energy metabolism of the muscle cells. 
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Figure 1.
Transmission electron microscopy image of silver nanopar-
ticles manufactured by the electric non-explosive method.
Figure 3.
Transmission electron microscopy image of pectoral muscle 
(cross section). Groups: Control, non injected; Nano-Ag, 
injected with silver nanoparticles; Glu, injected with 
glutamine; Nano-Ag/Glu, injected with silver nanoparticles 
and glutamine. (A) Single muscle fibre, (B) endomysium, 
(C) myofibrils. (D) nucleus.
Figure 2.
Light microscopy image of pectoral muscle (cross section). 
Groups: Control, non injected; Nano-Ag, injected with 
silver nanoparticles; Glu, injected with glutamine; 
Nano-Ag/Glu, injected with silver nanoparticles and 
glutamine. (A) Fascicle and (B) perymisium.
100 nm
Nano-AgControl
Nano-Ag/GluGlu
Nano-AgControl
Nano-Ag/GluGlu
It has been demonstrated that concentrations of certain amino acids in 
the egg, in late-term embryos, are not sufficient to fully support embryonic 
development18. During embryogenesis, energy and nutrients are mainly provided 
from the yolk, which is rich in lipids but low in carbohydrates8. Consequently, 
the embryo, and also post hatched chicken, depend on gluconeogenesis from 
amino acids19, which in turn decreases protein deposition in muscles, affecting 
the development of muscles5, 20. Moreover, after hatching when energy reserves 
are low, amino acids from pectoral muscle form the main substrates for 
gluconeogenesis19. Therefore, delivering extra amino acids to embryos could 
reduce such protein catabolism in muscles. 
Glutamine is an important substrate for the synthesis of amino acids 
necessary for muscle development; it is involved in gluconeogenesis and in 
maintaining the protein – energy balance in the muscle cells18, 21. Furthermore, 
glutamine is not only essential for protein synthesis, it is also a key source of 
nitrogen for the synthesis of purines, and it forms a source of carbon for energy 
production23. 
It has been demonstrated that nanoparticles of gold can affect muscle 
development and act as carries of nutrients into muscle cells21. However, only 
a few results indicate the potential effects of silver on chicken development23, 24 
and to date there is no information available concerning the application of silver 
nanoparticles as carries of nutrients into embryo tissues. In this investigation, we 
hypothesized that silver nanoparticles can affect muscle development of chicken 
embryos and, furthermore, they can be used in in ovo nutrition as carriers of nutrients 
into muscle cells. Nanoparticles can bypass conventional physiological ways of 
nutrient distribution and transport across tissue and cell membranes, as well as protect 
compounds against destruction prior to reaching their targets. In which case in ovo 
administration of nanoparticles, acting as bioactive agents and as carries of nutrients 
may be seen as a new method of nano-nutrition, providing embryos with bioactive 
compounds and/or with an additional quantity of nutrients or energy. 
The objective of the investigation was to evaluate the effect of 
nanoparticles of silver, glutamine and complexes of glutamine conjugated with 
silver nanoparticles on the expression of genes related to embryonic muscle 
development (FGF2, VEGF, MyoD1, PAX7, PCNA, and ATP1A1) and on the 
morphological characteristics of muscle.
Material and methods 
Experimental design
Ross × Ross 308 (broiler line) chicken eggs were obtained from a commercial 
hatchery. 160 eggs were randomly divided into four groups (4 x 40 eggs): without 
injection (Control), injected with hydrocolloid of Ag nanoparticles (Nano-Ag), 
injected with hydrocolloid of glutamine (Glu), injected with hydrocolloid of Ag 
nanoparticles with glutamine (Nano-Ag/Glu). Eggs were stored in a refrigerator 
(10 °C) for 1–3 days before being placed in an incubator. At day 1 of incubation, 
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the eggs were numbered, weighed (60.00 ± 1.36 g) and injected according to the 
above treatment descriptions. The eggs were injected into the air sac with 0.3 
ml of solutions using a sterile 27 gauge, 20 mm needle. Immediately after the 
injection, the hole was sealed with sterile tape and the eggs were replaced into 
an incubator. The eggs were incubated for 20 days under standard conditions 
(temperature 37.8 °C, humidity 55%, turned once per hour during the first 18 
days, at a temperature of 37 °C and humidity 60% from day 19). 
The embryos were evaluated on day 20 of incubation. The development 
status of chicken embryos was compared with the standard described by 
Hamburger and Hamilton (1951), furthermore, embryos were examined for 
any genetic defects25. The embryos were weighed together with the yolk sack, 
decapitated, and blood samples from the carotid artery were taken and collected 
in Eppendorf tubes (Eppendorf AG, Hamburg, Germany). The samples were 
incubated at room temperature until clotting and then centrifuged for 10 minutes 
(14.500 x g). The resulting blood serum samples were stored at -30°C until further 
analysis. The liver, heart, spleen and breast muscle were collected and weighed. 
Samples of the breast muscles were collected in RNAlater® ribonucleic acid 
(RNA) stabilization solution (Applied Biosystems/Ambion, Austin, TX, USA) 
for gene expression analysis or fixed in glutaraldehyde for electron microscopy 
preparation.
Solutions
Nanoparticles
The hydrocolloid of Ag-Nano (Figure 1) was obtained from Nano-Tech (Warsaw, 
Poland) and was produced by a non-explosive high voltage patented method 
(Polish Patent 3883399) from high purity metals (99.9999%) and high purity 
demineralized water. The concentration of nanoparticles in the hydrocolloids was 
50 ppm and the particle size ranged from 2 to 35 nm for Nano-Ag based on the 
transmission electron microscope (TEM) evaluation as previously described26.
Glutamine solutions
Pure L-Glutamine (Merck, Darmstadt, Germany) was dissolved in ultra-pure 
water at a concentration of 25 mg/ml. Furthermore, a hydrocolloid of Ag 
nanoparticles conjugated with glutamine was prepared by the self-organisation 
process using sonification for 30 min at 30˚C in an ultrasonic bath. The 
concentration of glutamine in the solution was 25 mg/ml.
Oxygen consumption  
The oxygen (O
2
) consumption was measured at days 10, 13, 16 and 19 of 
incubation, as previously described 27. The eggs were weighed and candled prior 
to the measurements to check for the presence of embryos. Eggs without an 
embryo were discarded and replaced with eggs of the same age from the same 
treatment kept in the incubator as reserves. The consumption of O
2
 was measured 
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according to the paramagnetic principle in an open-air-circuit respiration unit 
(Micro-Oxymax calorimeter from Columbus Instruments, Columbus, Ohio, 
USA), equipped with four respiration chambers with a volume of 2000 cm3 each. 
The temperature and relative humidity were maintained similar to that of the 
incubator. Six eggs from each treatment were placed in the respiration chambers 
and measured for 3 h from 9:00 to 12:00, followed by another six eggs from the 
same treatment measured from 13:00 to 16:00. After each measurement, the eggs 
were put back into the incubator. The measurements were standardized to a 50 g 
egg mass in order to account for differences in weight during each measurement.
Health and metabolic indices in the blood serum of chickens
The concentration of magnesium, calcium, phosphorus, triglycerides, 
cholesterol in very-low-density lipoprotein, glucose, and the activity of aspartate 
aminotransferase, alanine aminotransferase, alkaline phosphatase, and lactate 
dehydrogenase in blood serum was measured by dry chemistry methods (Vitros 
DT 60 II, Johnson and Johnson, New Brunswick, USA).
Microscopy visualization 
For observations using the TEM, tissues, obtained immediately after dissection, 
were cut into pieces of about 1 mm3 and fixed (60 min) in a 3% glutaraldehyde 
solution (Merck, Darmstadt, Germany) in 0.1 M sodium phosphate buffer (pH 7). 
Samples were then rinsed (2 x 5 min) in the same buffer and transferred to a 1% 
osmium tetroxide solution (Electron Microscope Science, Sigma-Aldrich) in 0.1 
M phosphate buffer (pH 6.9) for 1 hour. Subsequently, the samples were rinsed 
in 0.1 M sodium phosphate buffer (5 min), dehydrated in an ethanol (Merck, 
Darmstadt, Germany) gradient (50-99 %), and impregnated with Epon embedding 
resin (Merck, Darmstadt, Germany). The next day, the samples were embedded 
in the same resin and baked for 48 hours at 60°C. The blocks were cut into 
semi-thin sections for light microscopy (LM) using an ultra-microtome (Leica, 
ultracut UCT) and stained with 1% basic Toluidine blue. From selected regions 
of the tissue, ultrathin sections (50–80 nm) were cut and transferred onto copper 
grids (200 mesh). Subsequently, the sections were contrasted using 2 % uranyl 
acetate dihydrate and lead citrate (Reynolds). The structure of the chest muscles 
was visualized by a JEM-1220 TEM at 80 KeV (JEOL, Tokyo, Japan), with a 
Morada 11 megapixel camera (Olympus Soft Imaging Solutions GmbH, Münster, 
Germany).
Morphometry of the breast muscle of chicken embryos (fibre area, cell 
number per 1200 µm2 
and number of nuclei per 1200 µm2) was counted using ´´ImageJ´´ software 
(http://rsb.info.nih.gov/ij/). 
Gene expression at the RNA level
The tissue dissected from the breast muscle was homogenized in TRIzol® 
BJCCSB.ORG
Baltic Journal of Comparative & Clinical Systems Biologypage 33 
s
Reagent (Life Technologies), and total RNA was extracted according to the 
manufacturer’s instructions. The RNA samples were purified, using the SV Total 
RNA Isolation System (Promega Corporation, Madison, WI, USA) and quantified 
using a NanoDrop ND 1000 spectrophotometer (Thermo Fisher Scientific, 
Waltham, MA, USA). Using reverse transcriptase with oligo (dT) (Promega) 
and random primers (TAG Copenhagen A/S, Copenhagen, Denmark), 2 mg of 
total RNA was reverse transcribed, after which real-time PCR was performed 
with complementary DNA and gene specific primer pairs (TAG Copenhagen, 
Denmark) mixed with LightCycler®480 SYBR Green I Master mix (Roche 
Applied Science, Penzberg, Germany) in a LightCycler®480 real-time PCR 
system (Roche Applied Science, Penzberg, Germany). The samples were first 
denatured for 5 minutes at 95°C and then amplified using 45 cycles of 10 seconds 
at 95°C (denaturation), 10 seconds at 60°C–62°C (annealing), and 9 seconds 
at 72°C (elongation), followed by quantification. A melting curve program 
(56°C–97°C with a heating rate of 0.11°C/second and five acquisitions per 1°C) 
was applied to verify the specificity of the product. For each complementary 
DNA, the reaction was performed in triplicate. For analyses, relative 
quantification was applied with beta-actin (ACTB) used as the housekeeping 
genes.
Gene expression of FGF2 (Fibroblast Growth Factor 2) and VEGF (Vascular 
Endothelial Growth Factor) at the protein level (ELISA method)
Frozen breast muscle tissue samples were homogenized on ice using RIPA 
lysis and extraction buffer (Thermo Fisher Scientific) and a Polytron® PT 2100 
homogenizer (Kinematica AG, Lucerne, Switzerland). Homogenates were left 
on ice for 30 minutes and were subsequently centrifuged for 20 minutes (4°C, 
12,500 rpm). The supernatant was collected in chilled Eppendorf PCR tubes 
(Eppendorf AG, Hamburg, Germany). Supernatant samples were divided into two 
equal portions. One was used to evaluate the total protein concentration (Total 
Protein Kit, Micro Lowry, Peterson’s Modification; Sigma-Aldrich). The second 
portion was used to perform the enzyme-linked immunosorbent test, using an 
Enzymelinked Immunosorbent Assay Kit (USCN Life Science, Tokyo, Japan). 
Reagents and plates were prepared accordingly to the manufacturer’s standard 
procedure and incubated for 25 minutes under standard conditions. The degree 
of absorption was measured in a microplate reader Infinite®M200 PRO (Tecan 
Deutschland GmbH, Crailsheim, Germany).
2.8. Statistical methods 
Data analysis was carried out using the one-way analysis of variance (ANOVA) 
test-generalized linear model (Tukey-Cramer) (GLM) procedure in SAS 9.2 (SAS 
Windows, 2002-2008, version 9.2, SAS Institute INC., Cary, NY, USA). Mean 
values differing with a P<0.05 were considered significantly different.
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3. Results
Nano-Ag, Glu and Nano-Ag/Glu did not affect the weight of the liver, heart 
and spleen of embryos. However, the muscle percentage of body weight was 
significantly higher with Nano-Ag/Glu treatment compared to the other groups 
(Table 1). Embryo visualization did not show any genetic defects among the 
groups. Furthermore, comparison with Hamburger-Hamilton normal stages of 
chicken embryo development showed that all embryos had developed normally. 
In addition, all of the biochemical indices measured in the blood serum of chicken 
embryos did not show significant effects of treatment (Table 2).
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 Treatment 
 Control  Nano-Ag Glu  Nano-Ag/Glu 
 mean SEM mean SEM mean SEM mean SEM P-value
FGF2 0.73a 0.031 0.94b 0.047 0.79ab 0.027 0.84ab 0.061 0.008
VEGF 0.57a 0.067 1.34b 0.213 2.08c 0.143 0.78a 0.052 0.0001
PAX7 1.15 0.051 0.91 0.062 1.25 0.218 1.38 0.049 0.087
PCNA 0.92a 0.052 1.01a 0.048 1.07a 0.092 1.54b 0.099 0.001
MyoD1 0.68a 0.033 1.57b 0.141 0.62a 0.048 1.00c 0.074 0.001
ATP1A1 0.92a 0.059 1.38b 0.126 1.13ab 0.126 0.80a 0.054 0.0015
Table 5.  Gene expression at the mRNA level (Polymerase Chain 
                             Reaction) in the breast muscle tissue of chicken embryos
Within rows: means with different superscript differed significantly (P < 0.05).
Abbreviations: SEM – standard error of mean. Groups: Control, non injected; Nano-Ag, injected with silver 
nanoparticles; Glu, injected with glutamine; Nano-Ag/Glu, injected with silver nanoparticles and glutamine. FGF2, 
Fibroblast Growth Factor 2; VEGF, Vascular Endothelial Growth Factor; PAX7, Pair Box transcription Factor 7; PCNA, 
Proliferating Cell Nuclear Antigen; MyoD1, Myogenic Differentiation Factor; ATP1A1, ATPase. 
 Treatment 
 Control  Nano-Ag Glu  Nano-Ag/Glu 
 mean SEM mean SEM mean SEM mean SEM P-value
FGF 24.4a 3.31 46.7b 1.63 34.7ab 3.82 44.4b 3.21 0.0011
VEGF 32.4a 1.51 62.6b 3.25 46.2c 1.44 40.8ac 2.71 0.0001
Table 4  .  Gene expression at the protein level (Enzyme-linked 
 immunosorbent assay) in the breast muscle tissue of 
 chicken embryo 
Within rows: means with different superscript differed significantly (P < 0.05).
Abbreviations: SEM – standard error of mean. Groups: Control, non injected; Nano-Ag, injected with silver 
nanoparticles; Glu, injected with glutamine; Nano-Ag/Glu, injected with silver nanoparticles and glutamine. FGF2, 
Fibroblast Growth Factor 2; VEGF, Vascular Endothelial Growth Factor. 
 Treatment 
 Control  Nano-Ag Glu  Nano-Ag/Glu 
 mean SEM mean SEM mean SEM mean SEM P-value
Alkaline phosphatase (U/L) 6125 521 6439 452 7023 807 6945 502 0.68
Aspartate aminotransferase (U/L) 178 21 166 24 126 23 166 27 0.22
Alanine aminotransferase (U/L) 3.7 0.33 4.3 0.33 2.0 0 3.33 0.33 0.06
Lactate dehydrogenase (U/L) 1778 358 2219 709 1360 48.5 2012 122 0.51
Magnesium (mmol/L) 0.9 0.02 0.9 0.01 0.9 0.04 0.9 0.01 0.33
Calcium (mmol/L) 2.3 0.08 2.1 0.12 2.1 0.11 2.1 0.07 0.75
Phosphate (mmol/L) 1.3 0.01 1.5 0.15 1.4 0.03 1.4 0.13 0.64
Triglycerides (mmol/L) 1.0 0.04 1.4 0.11 1.0 0.05 1.0 0.12 0.01
Cholesterol (mmol/L) 11 1.7 12 1.45 11 0.27 10 0.71 0.76
Glucose (mmol/L) 14.9 0.28 14.8 1.02 13.5 0.44 13.3 0.55 0.25
Table 2.  Table 2 Biochemical indices measured in the blood 
 serum of chicken embryos
Abbreviations: Groups:  SEM – standard error of mean. Groups: Control, non injected; Nano-Ag, injected with silver 
nanoparticles; Glu, injected with glutamine; Nano-Ag/Glu, injected with silver nanoparticles and glutamine.
 Treatment 
 Control  Nano-Ag Glu  Nano-Ag/Glu 
 mean SEM mean SEM mean SEM mean SEM P-value
Embryo, % e.w1 78 1.52 76 1.72 76 0.5 75 0.88 0.28
Liver, % b.w2 1.5 0.05 1.4 0.05 1.4 0.04 1.4 0.04 0.095
Heart, % b.w2 0.5 0.01 0.5 0.01 0.5 0.01 0.5 0.01 0.14
Spleen, % b.w2 0.04 0.002 0.05 0.009 0.03 0.002 0.03 0.002 0.07
Muscle, % b.w2 0.81a 0.035 0.80a 0.051 0.72a 0.062 1.04b 0.080 0.003
Table 1.  Average weight of chicken embryos, organs and 
 pectoral muscle
Within rows: means with different superscript differ significantly (P < 0.05).
Abbreviations: 1% of egg weight; 2% of body weight. SEM – standard error of mean. Groups: Control, non injected; 
Nano-Ag, injected with silver nanoparticles; Glu, injected with glutamine; Nano-Ag/Glu, injected with silver 
nanoparticles and glutamine.
  Treatment 
  Control  Nano-Ag Glu  Nano-Ag/Glu 
 mean SEM mean SEM mean SEM mean SEM  P-value
Cell number/1200µm2 17.0a 0.27 12.2c 0.25 13.6b 0.58 9.8c 0.31 0.0001
Number of nuclei/1200µm2 7.2 0.67 8.2 0.53 7.8 0.68 6.5 0.33 0.001
Nuclei/Cell  0.42  0.67  0.57  0.67  
Fiber area (µm2) 38a 1.62 79c 3.06 58b 1.87 74c 1.98 0.001
Table 3.  Morphometry of the breast muscle of chicken embryos
Within rows: means with different superscript differ significantly (P < 0.05).
Abbreviations: SEM – standard error of mean. Groups: Control, non injected; Nano-Ag, injected with silver 
nanoparticles; Glu, injected with glutamine; Nano-Ag/Glu, injected with silver nanoparticles and 
glutamine.
 Treatment 
 Control  Nano-Ag Glu  Nano-Ag/Glu 
 mean SEM mean SEM mean SEM mean SEM P-value
FGF2 0.73a 0.031 0.94b 0.047 0.79ab 0.027 0.84ab 0.061 0.008
VEGF 0.57a 0.067 1.34b 0.213 2.08c 0.143 0.78a 0.052 0.0001
PAX7 1.15 0.051 0.91 0.062 1.25 0.218 1.38 0.049 0.087
PCNA 0.92a 0.052 1.01a 0.048 1.07a 0.092 1.54b 0.099 0.001
MyoD1 0.68a 0.033 1.57b 0.141 0.62a 0.048 1.00c 0.074 0.001
ATP1A1 0.92a 0.059 1.38b 0.126 1.13ab 0.126 0.80a 0.054 0.0015
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Table 1.  Average weight of chicken embryos, organs and 
 pectoral muscle
Within rows: means with different superscript differ significantly (P < 0.05).
Abbreviations: 1% of egg weight; 2% of body weight. SEM – standard error of mean. Groups: Control, non injected; 
Nano-Ag, injected with silver nanoparticles; Glu, injected with glutamine; Nano-Ag/Glu, injected with silver 
nanoparticles and glutamine.
  Treatment 
  Control  Nano-Ag Glu  Nano-Ag/Glu 
 mean SEM mean SEM mean SEM mean SEM  P-value
Cell number/1200µm2 17.0a 0.27 12.2c 0.25 13.6b 0.58 9.8c 0.31 0.0001
Number of nuclei/1200µm2 7.2 0.67 8.2 0.53 7.8 0.68 6.5 0.33 0.001
Nuclei/Cell  0.42  0.67  0.57  0.67  
Fiber area (µm2) 38a 1.62 79c 3.06 58b 1.87 74c 1.98 0.001
Table 3.  Morphometry of the breast muscle of chicken embryos
Within rows: means with different superscript differ significantly (P < 0.05).
Abbreviations: SEM – standard error of mean. Groups: Control, non injected; Nano-Ag, injected with silver 
nanoparticles; Glu, injected with glutamine; Nano-Ag/Glu, injected with silver nanoparticles and 
glutamine.
Chicken embryo breast muscle tissues were visualized using LM and 
TEM, which enabled observation of the structure of the pectoral muscle. There 
were visual changes in the 
structure of the cross section 
of breast muscle in the 
treated groups compared to 
the embryos from the control 
group. According to LM in 
the Nano-Ag/Glu group, 
bundles of muscle fibres 
formed the most compact 
and rounded structure. In 
addition, the perimysium 
in the Nano-Ag/Glu group 
was smaller compared to the 
other groups. Furthermore, 
the visual bundle area was 
larger in the Nano-Ag and 
Nano-Ag/Glu groups when 
compared with the control 
group (Figure 2). 
Visualization of 
transverse sections of the 
pectoral muscle samples 
using TEM showed (Figure 
3) that muscles cells from 
the control group were the 
smallest and that the space 
between the cells was wider 
than in the other groups. 
Within cells, myofibrils were 
loosely placed with relatively 
long distances between 
myofibrils, moreover, 
myomere decay, unification 
of myosin and actin filaments 
and occasional myelin 
structures were noticed. The 
muscle fibre area was larger 
in Nano-Ag and Nano-Ag/
Glu. Furthermore, myofibrils 
of treated embryos were more 
concentrated, compact and 
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Figure 1.
Transmission electron microscopy image of silver nanopar-
ticles manufactured by the electric non-explosive method.
Figure 3.
Transmission electron microscopy image of pectoral muscle 
(cross section). Groups: Control, non injected; Nano-Ag, 
injected with silver nanoparticles; Glu, injected with 
glutamine; Nano-Ag/Glu, injected with silver nanoparticles 
and glutamine. (A) Single muscle fibre, (B) endomysium, 
(C) myofibrils. (D) nucleus.
Figure 2.
Light microscopy image of pectoral muscle (cross section). 
Groups: Control, non injected; Nano-Ag, injected with 
silver nanoparticles; Glu, injected with glutamine; 
Nano-Ag/Glu, injected with silver nanoparticles and 
glutamine. (A) Fascicle and (B) perymisium.
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Nano-Ag/Glu, injected with silver nanoparticles and 
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placed more regularly than the controls. Muscle cells of chickens from the Nano-
Ag/Glu group were surrounded with regular, smooth and well convex membranes. 
Quantitative measurements demonstrated that the control group had a 
significantly higher number of muscle cells compared to the remaining groups (Table 
3). However, significantly the biggest pectoral muscle fibre areas were found in the 
Nano-Ag (79 µm2) and Nano-Ag/Glu (74 µm2) groups. The numbers of nuclei on the 
quadratic surface of the cross section image (1200 µm2) were the same for all groups.  
Although, the proportion between the number of nuclei and the cell number was 
higher in the Nano-Ag (0.67) and Nano-Ag/Glu (0.67) groups compared to the Glu 
(0.57) and Control (0.42) groups. 
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Figure 4. Day of incubation
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Figure 4. Mean oxygen consumption (ml/h-1) of chicken embryos measured at days 10, 13, 16 and 19 of 
incubation. Groups: Control, non injected; Nano-Ag, injected with silver nanoparticles; Glu, injected with 
glutamine; Nano-Ag/Glu, injected with silver nanoparticles and glutamine.
 Treatment 
 Control  Nano-Ag Glu  Nano-Ag/Glu 
 mean SEM mean SEM mean SEM mean SEM P-value
FGF2 0.73a 0.031 0.94b 0.047 0.79ab 0.027 0.84ab 0.061 0.008
VEGF 0.57a 0.067 1.34b 0.213 2.08c 0.143 0.78a 0.052 0.0001
PAX7 1.15 0.051 0.91 0.062 1.25 0.218 1.38 0.049 0.087
PCNA 0.92a 0.052 1.01a 0.048 1.07a 0.092 1.54b 0.099 0.001
My D1 0.68a 0.033 1.57b 0.141 0.62a 0.048 1.00c 0.074 0.001
ATP1A1 0.92a 0.059 1.38b 0.126 1.13ab 0.126 0.80a 0.054 0.0015
Table 5.  Gene expression at the mRNA level (Polymerase Chain 
                             Reaction) in the breast muscle tissue of chicken embryos
Within rows: means with different superscript differed significantly (P < 0.05).
Abbreviations: SEM – standard error of mean. Groups: Contro , non injected; Nano-Ag, injected with silver 
nanoparticles; Glu, injected with glutamine; Nano-Ag/Glu, injected with silver nanoparticles and glutamine. FGF2, 
Fibroblast Growth Factor 2; VEGF, Vascular Endothelial Growth Factor; PAX7, Pair Box transcription Factor 7; PCNA, 
Proliferating Cell Nuclear Antigen; MyoD1, Myogenic Differentiation Factor; ATP1A1, ATPase. 
 Treatment 
 Control  Nano-Ag Glu  Nano-Ag/Glu 
 mean SEM mean SEM mean SEM mean SEM P-value
FGF 24.4a 3.31 46.7b 1.63 34.7ab 3.82 44.4b 3.21 0.0011
VEGF 32.4a 1.51 62.6b 3.25 46.2c 1.44 40.8ac 2.71 0.0001
Table 4  .  Gene expression at the protein level (Enzyme-linked 
 immunosorbent assay) in the breast muscle tissue of 
 chicken embryo 
Within rows: means with different superscript differed significantly (P < 0.05).
Abbreviations: SEM – standard error of mean. Groups: Control, non injected; Nano-Ag, injected with silver 
nanoparticles; Glu, injected with glutamine; Nano-Ag/Glu, injected with silver nanoparticles and glutamine. FGF2, 
Fibroblast Growth Factor 2; VEGF, Vascular Endothelial Growth Factor. 
 Treatment 
 Control  Nano-Ag Glu  Nano-Ag/Glu 
 mean SEM mean SEM mean SEM mean SEM P-value
Alkaline phosphatase (U/L) 6125 521 6439 452 7023 807 6945 502 0.68
Aspartate aminotransferase (U/L) 178 21 166 24 126 23 166 27 0.22
Alanine aminotransferase (U/L) 3.7 0.33 4.3 0.33 2.0 0 3.33 0.33 0.06
Lactate dehydrogenase (U/L) 1778 358 2219 709 1360 48.5 2012 122 0.51
Magnesium (mmol/L) 0.9 0.02 0.9 0.01 0.9 0.04 0.9 0.01 0.33
Calcium (mmol/L) 2.3 0.08 2.1 0.12 2.1 0.11 2.1 0.07 0.75
Phosphate (mmol/L) 1.3 0.01 1.5 0.15 1.4 0.03 1.4 0.13 0.64
Triglycerides (mmol/L) 1.0 0.04 1.4 0.11 1.0 0.05 1.0 0.12 0.01
Cholesterol (mmol/L) 11 1.7 12 1.45 11 0.27 10 0.71 0.76
Glucose (mmol/L) 14.9 0.28 14.8 1.02 13.5 0.44 13.3 0.55 0.25
Table 2.  Table 2 Biochemical indices measured in the blood 
 serum of chicken embryos
Abbreviations: Groups:  SEM – standard error of mean. Groups: Control, non injected; Nano-Ag, injected with silver 
nanoparticles; Glu, injected with glutamine; Nano-Ag/Glu, injected with silver nanoparticles and glutamine.
 Treatment 
 Control  Nano-Ag Glu  Nano-Ag/Glu 
 mean SEM mean SEM mean SEM mean SEM P-value
Embryo, % e.w1 78 1.52 76 1.72 76 0.5 75 0.88 0.28
Liver, % b.w2 1.5 0.05 1.4 0.05 1.4 0.04 1.4 0.04 0.095
Heart, % b.w2 0.5 0.01 0.5 0.01 0.5 0.01 0.5 0.01 0.14
Spleen, % b.w2 0.04 0.002 0.05 0.009 0.03 0.002 0.03 0.002 0.07
Muscle, % b.w2 0.81a 0.035 0.80a 0.051 0.72a 0.062 1.04b 0.080 0.003
Table 1.  Average weight of chicken embryos, organs and 
 pectoral muscle
Within rows: means with different superscript differ significantly (P < 0.05).
Abbreviations: 1% of egg weight; 2% of body weight. SEM – standard error of mean. Groups: Control, non injected; 
Nano-Ag, injected with silver nanoparticles; Glu, injected with glutamine; Nano-Ag/Glu, injected with silver 
nanoparticles and glutamine.
  Treatment 
  Control  Nano-Ag Glu  Nano-Ag/Glu 
 mean SEM mean SEM mean SEM mean SEM  P-value
Cell number/1200µm2 17.0a 0.27 12.2c 0.25 13.6b 0.58 9.8c 0.31 0.0001
Number of nuclei/1200µm2 7.2 0.67 8.2 0.53 7.8 0.68 6.5 0.33 0.001
Nuclei/Cell  0.42  0.67  0.57  0.67  
Fiber area (µm2) 38a 1.62 79c 3.06 58b 1.87 74c 1.98 0.001
Table 3.  Morphometry of the breast muscle of chicken embryos
Within rows: means with different superscript differ significantly (P < 0.05).
Abbreviations: SEM – standard error of mean. Groups: Control, non injected; Nano-Ag, injected with silver 
nanoparticles; Glu, injected with glutamine; Nano-Ag/Glu, injected with silver nanoparticles and 
glutamine.
Oxygen consumption (Figure 4) measured at day 10, 13, 16 and 19 of 
incubation was not significantly different between the treatments. However, at the 
end of incubation there was a visible decrease in O
2
 consumption for the Nano-Ag 
group compared with the other groups. 
At the protein level (Table 4), expression of FGF2 increased significantly 
for Nano-Ag (46.7) and Nano-Ag/Glu complex (44.4) compared to the control 
group (24.4). There was no significant effect of glutamine (34.7), however, 
there was a noticeable increase compared to the control group. Furthermore, 
Nano-Ag (62.6), Glu (46.2) and Nano-Ag/Glu (40.8) significantly increased 
the expression of VEGF at the protein level compared to that of the Controls 
(32.4). At the mRNA level (Table 5), the expression of FGF2 was increased 
in the Nano-Ag group (0.94) compared to the control group (0.73). Regarding 
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 Treatment 
 Control  Nano-Ag Glu  Nano-Ag/Glu 
 mean SEM mean SEM mean SEM mean SEM P-value
FGF2 0.73a 0.031 0.94b 0.047 0.79ab 0.027 0.84ab 0.061 0.008
VEGF 0.57a 0.067 1.34b 0.213 2.08c 0.143 0.78a 0.052 0.0001
PAX7 1.15 0.051 0.91 0.062 1.25 0.218 1.38 0.049 0.087
PCNA 0.92a 0.052 1.01a 0.048 1.07a 0.092 1.54b 0.099 0.001
MyoD1 0.68a 0.033 1.57b 0.141 0.62a 0.048 1.00c 0.074 0.001
ATP1A1 0.92a 0.059 1.38b 0.126 1.13ab 0.126 0.80a 0.054 0.0015
Table 5.  Gene expression at the mRNA level (Polymerase Chain 
                             Reaction) in the breast muscle tissue of chicken embryos
Within rows: means with different superscript differed significantly (P < 0.05).
Abbreviations: SEM – standard error of mean. Groups: Control, non injected; Nano-Ag, injected with silver 
nanoparticles; Glu, injected with glutamine; Nano-Ag/Glu, injected with silver nanoparticles and glutamine. FGF2, 
Fibroblast Growth Factor 2; VEGF, Vascular Endothelial Growth Factor; PAX7, Pair Box transcription Factor 7; PCNA, 
Proliferating Cell Nuclear Antigen; MyoD1, Myogenic Differentiation Factor; ATP1A1, ATPase. 
 Treatment 
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VEGF 32.4a 1.51 62.6b 3.25 46.2c 1.44 40.8ac 2.71 0.0001
Table 4  .  Gene expression at the protein level (Enzyme-linked 
 immunosorbent assay) in the breast muscle tissue of 
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Within rows: means with different superscript differed significantly (P < 0.05).
Abbreviations: SEM – standard error of mean. Groups: Control, non injected; Nano-Ag, injected with silver 
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Fibroblast Growth Factor 2; VEGF, Vascular Endothelial Growth Factor. 
 Treatment 
 Control  Nano-Ag Glu  Nano-Ag/Glu 
 mean SEM mean SEM mean SEM mean SEM P-value
Alkaline phosphatase (U/L) 6125 521 6439 452 7023 807 6945 502 0.68
Aspartate aminotransferase (U/L) 178 21 166 24 126 23 166 27 0.22
Alanine aminotransferase (U/L) 3.7 0.33 4.3 0.33 2.0 0 3.33 0.33 0.06
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Table 1.  Average weight of chicken embryos, organs and 
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Within rows: means with different superscript differ significantly (P < 0.05).
Abbreviations: 1% of egg weight; 2% of body weight. SEM – standard error of mean. Groups: Control, non injected; 
Nano-Ag, injected with silver nanoparticles; Glu, injected with glutamine; Nano-Ag/Glu, injected with silver 
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  Treatment 
  Control  Nano-Ag Glu  Nano-Ag/Glu 
 mean SEM mean SEM mean SEM mean SEM  P-value
Cell number/1200µm2 17.0a 0.27 12.2c 0.25 13.6b 0.58 9.8c 0.31 0.0001
Number of nuclei/1200µm2 7.2 0.67 8.2 0.53 7.8 0.68 6.5 0.33 0.001
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Table 3.  Morphometry of the breast muscle of chicken embryos
Within rows: means with different superscript differ significantly (P < 0.05).
Abbreviations: SEM – standard error of mean. Groups: Control, non injected; Nano-Ag, injected with silver 
nanoparticles; Glu, injected with glutamine; Nano-Ag/Glu, injected with silver nanoparticles and 
glutamine.
the VEGF expression, there was a significant increase for the Nano-Ag (1.34) 
and also for Glu (2.08) treated chick embtros, which had the highest level of 
expression compared to the control group (0.57). When Pax 7 was examined, 
the level of expression was lowest in the Nano-Ag group (0.91), however, 
differences between treatments were not significantly different. Nano-Ag/Glu 
(1.54) significantly increased the expression of PCNA compared to the other 
groups (Control: 0.92; Nano-Ag: 1.01; Glu: 1.07).  Nano-Ag (1.57) and Nano-Ag/
Glu (1.0) significantly increased the expression of MyoD1, compared to the other 
groups (Control: 0.68; Glu: 0.62). Furthermore, Nano-Ag (1.38) significantly 
increased the level of ATP1A1 expression but only compared to the Controls 
(0.92) and the Nano-Ag/Glu group (0.80). 
Discussion
The results of the present experiment show that colloids of silver nanoparticles 
administrated at a low level (50 ppm) do not negatively affect chicken embryo 
growth and development. The weight of embryos and organs, as well as 
biochemical indices, measured in the blood serum, did not point towards any 
negative changes, being in agreement with previous results from experiments 
carried out in vitro28, 29, in vivo 30, 31, 32 and also in ovo33, 34, 35. However, the 
toxicity of silver nanoparticles remains controversial and is far from completely 
understood36. In the present study the indices for chicken embryo growth and 
development were also not affected by the administration of glutamine as well 
as glutamine conjugated with Nano-Ag. Glutamine is a natural component of 
the body, therefore, we supposed that when used at a low level it should be non-
toxic, especially since glutamine has shown beneficial properties, preventing 
chemotherapy and radiation-induced toxicity in humans37. 
Nano-Ag, glutamine and the complex of Nano-Ag/Glu were non-toxic, 
however, the supplements were also not neutral in terms of the chicken embryo. 
Colloids of silver nanoparticles increased mRNA expression of genes FGF2 
and VEGFA, which suggests that silver nanoparticles may activate growth and 
development at the molecular level, as has indeed been demonstrated previously11. 
In the present experiment the expression of MyoD1 and ATP1A1 was also up-
regulated by silver nanoparticles, when compared to the control group. The up-
regulation of MyoD1 indicates that nanoparticles of silver activate myogenesis. 
In general this process is strictly limited by oxygen and nutrient availability 
and consequently by the rate of metabolism, especially by the O
2
 dependent 
mechanisms of oxidation38,39 and the amount of energy stored within the cell. 
The energetic state of the cells is related to the activities of the protein, encoded 
by the ATP1A1 gene, which belongs to the family of P-type cation transport 
ATPases - Na+/K+40. The activity of such ATPases is related to the balance of O
2
 
in the mitochondrial respiratory chain reactions41. Non-adequate amounts of O
2
 
in the muscle can limit its development. Silver has the ability to absorb O
2
, and it 
has been suggested, that oxygen species coexist on the surface of silver42, 43. We 
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propose that silver nanoparticles, acting as small delivery vehicles are capable of 
crossing cell membranes and of transporting O
2
 directly to muscle cells. In the 
present experiment Nano-Ag treatment insignificantly decreased O
2
 consumption 
at the end of embryogenesis compared to the control group (Figure 4). This may 
indicate that the requirement for O
2 
was partially covered by O
2
 transported by 
Ag, however, further experiments are needed to confirm this tendency. 
Silver nanoparticles, administered to the embryos increased the expression 
of FGF2 and VEGFA at the mRNA and protein levels. The FGF2 gene is involved 
in the regulation of muscle growth as a strong stimulator of myoblast and satellite 
cells proliferation and an inhibitor of their differentiation1. The activities of FGF2 
during embryogenesis decrease around hatching when the number of muscle cells 
is almost stable 43. However, in the present experiment FGF2 was up-regulated 
both at the mRNA and protein levels at day 20 (just before hatching). This may 
indicate that nanoparticles are capable of sustaining muscle cell proliferation and/
or inhibiting signals that turn on the process of differentiation in these muscle 
cells. Furthermore, VGFA was up-regulated, indicating that nanoparticles may 
promote the growth of vascular endothelial cells and stimulate angiogenesis. 
Silver nanoparticles increased the mRNA expression of MyoD1, which 
controls embryonic myogenesis at all stages of muscle development, as well as in 
adult tissue44, 45, 46, 47, 48. MyoD1 is expressed in proliferating myoblasts and encodes 
for nuclear proteins, which regulate muscle cell differentiation by cell cycle arrest 
stimulation39, 49. Cell cycle regulation processes are dependent on PCNA activities, 
which was not affected by our Nano-Ag. We therefore expect that the activation 
of extra signals involved in proliferation of muscle’s cells also requires an extra 
amount of energy and/or nutrients to finish the process of proliferation and to start 
the process of differentiation. 
Interestingly, the results observed upon injection of Nano-Ag were contrary 
to the results observed after the application of silver nanoparticles conjugated with 
glutamine. The expression of ATP1A1 at the mRNA level decreased compared 
to Nano-Ag, yet was similar to values for the control group. Furthermore, the 
expression of VEGF and MyoD1 was found to be down-regulated, indicating 
contrary effects to those obtained with Ag-Nano. However, MyoD1 was expressed 
at a lower level in the Nano-Ag/Glu group than in the Nano-Ag group, although 
still at a higher level than in the control group. The expression of PCNA increased 
in comparison to all the other groups. PCNA plays an important role in nucleic 
acid homeostasis, as a component of the replication of DNA synthesis and DNA 
repair50. 
Glutamine, after glucose, is the next primary carbon source for ATP 
production and DNA biosynthesis in proliferating mammalian cells51. We 
propose that glutamine, when transported with silver nanoparticles is protected 
against breakdown as well as facilitating the direct delivery of this compound 
to cells. When we observed results obtained by visualization of the samples, the 
average cell number per area was found to be lower in all the injected groups 
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compared with the control group, but the average number of nuclei in proportion 
to the number of cells was found to be higher. Furthermore, the fibre area was 
significantly increased in the treatment groups, compared to the control group. 
Thus in every case major effects were seen for the Nano-Ag and Nano-Ag/
Glu groups compared with the controls. These results indicate a significant role 
for silver nanoparticles in muscle development, a role that is sustained or even 
enhanced by the use of a Nano-Ag/Glutamine complex. Moreover, the application 
of nano silver with glutamine significantly increased the mass of the pectoral 
muscle as compared with the control group, and also when compared with the 
Nano-Ag and Glu groups. This overall promoting effect of Nano-Ag/Glu on 
muscle development supports our hypothesis that silver nanoparticles act as 
carriers of glutamine to the cells. Indeed, provision of muscle cells with glutamine 
in this way would be expected to improve nucleic acid synthesis and metabolic 
programing within cell, increasing their fibre area and consequently muscle mass.
Conclusion
Nanoparticles of silver, glutamine and complexes of Nano-Ag with glutamine 
were without negative effects on embryo development. Nano-Ag and Nano-Ag/
Glu affected the expression of genes responsible for muscle development during 
embryogenesis. However, the molecular effects were not consistent for Nano-
Ag compared with those for Nano-Ag/Glu. Nano-Ag and Nano-Ag/Glu affected 
muscle morphology by increasing the number of nuclei per cell, and by increasing 
fiber area. Moreover, the complex of Nano-Ag with glutamine increased muscle 
mass.
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